In 2003, Sean George, director of business segments for cell biology, made the cover of Invitrogen’s annual report after moving into his position from Molecular Probes, which Invitrogen acquired that August. Today, George has a new position as vice president of diagnostic tools and solutions for Invitrogen and will be responsible for guiding the integration of the firm’s technology with that of Dynal, which Invitrogen this week said it plans to acquire for $386 million in a transaction that is expected to close in April (see article, page 1).

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.

Retraction Watch's Ivan Oransky and Adam Marcus report that Harvard Medical School and Brigham and Women's Hospital have recommended that more than 30 papers from a former researcher be retracted.

Thomas Steitz, who won the 2009 chemistry Nobel Prize for his ribosome work, has died, the Washington Post reports.

In PLOS this week: mechanisms for genes implicated in coronary artery disease, rumen microbes and host genetics influence cow methane production, and more.